MyFinsight
Home
Blog
About
Back
Income Statement
Pelthos Therapeutics Inc. (PTHS)
Pelthos Therapeutics Inc. (PTHS)
source: myfinsight.com
Comprehensive loss
-$23,527K
Net loss
-$23,417K
(-578.96%↓ Y/Y)
Change in fair value of
convertible debt due to...
-$110K
Net loss before
provision for income taxes
-$23,417K
(-578.96%↓ Y/Y)
Product
$15,420K
License And
Collaboration
$183K
Operating loss
-$17,323K
(-436.25%↓ Y/Y)
Total other expense
-$6,094K
(-2688.81%↓ Y/Y)
Total revenue
$15,603K
Total operating
expenses
$32,926K
(919.25%↑ Y/Y)
Change in fair value of
convertible debt
-$3,705K
Interest expense
$2,389K
(993.28%↑ Y/Y)
Selling, general and
administrative
$27,673K
Cost of goods sold
$3,610K
Amortization of intangible
assets
$1,043K
Research and development
$600K
(16.55%↑ Y/Y)
Back